This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.

Browse

Exemestane

Steroidal suicide AI used clinically for ER+ breast cancer and off-label in TRT/AAS contexts to control aromatization.

Aliases (3)
Aromasin · EXE · steroidal AI
TYPICAL DOSE
ROUTE
CYCLE
STORAGE

Overview

What is Exemestane?

Steroidal suicide AI used clinically for ER+ breast cancer and off-label in TRT/AAS contexts to control aromatization. Differs from anastrozole by irreversible binding (longer functional half-life despite shorter pharmacokinetic half-life) and mild intrinsic androgenicity. Not a standalone biohacking tool.

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.

Side Effects & Safety

  • Common: hot flashes, fatigue, joint stiffness (less than non-steroidal AIs in head-to-head trials).
  • Less common: insomnia, mood disturbance, transient liver enzyme elevation.
  • Chronic use: measurable bone-density loss after 1-2 years post-menopausal indication. Not seen with short cycle/PCT use.
  • Sex-specific: for a young male with intact HPG, suppression below ~15 pg/mL estradiol commonly produces libido collapse, joint pain, mood crash.
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources